on MediClin AG (isin : DE0006595101)
MEDICLIN Increases 2024 Full-Year Financial Projections
MEDICLIN Aktiengesellschaft, based in Offenburg, has announced an upward revision of its financial guidance for the 2024 fiscal year. Initially projecting a Group EBIT between EUR 33.0 and 39.0 million, the company now anticipates EBIT ranging from EUR 48.0 to 54.0 million. This adjustment reflects a significant improvement in expected financial performance.
The sales forecast has also been adjusted. Originally set between a decrease of 2.0% and no growth, it now predicts an increase between 1.0% and 3.0%. These revised figures suggest a more optimistic outlook compared to previous estimations. Preliminary figures for both the fourth quarter and the overall 2024 financial year are scheduled for release on 27 February 2025.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MediClin AG news